Actively Recruiting
Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma
Led by Hospital Universitari de Bellvitge · Updated on 2024-10-22
108
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Introduction: Asthma is one of the most common chronic respiratory diseases worldwide. Despite the extensive knowledge of the condition and available therapeutic options, severe asthmatic patients have poor disease control in 50% of cases. Objective: To assess the impact of implementing a mobile application (ESTOI) in patients diagnosed with asthma on disease control, treatment adherence, and perceived quality of life. Methodology: A 52-week randomized clinical trial involving asthma patients receiving care at a highly specialized hospital in Spain. A total of 108 patients will be included and divided into two groups. The intervention group will receive more comprehensive monitoring than usual, including access to the ESTOI application. The Asthma Control Test (ACT) questionnaire will be used as the primary assessment variable. Other variables to be studied include the Inhaler Adherence Test (TAI), the number of exacerbations, peak expiratory flow, exhaled nitric oxide examination, hospital anxiety and depression scale, asthma quality of life questionnaire, forced spirometry parameters (FVC, FEV1, and reversibility), and analytical parameters (eosinophilia and IgE).
CONDITIONS
Official Title
Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older with a diagnosis of asthma based on GEMA 5.2 2022
- Patients receiving care at the pulmonology service of the study center
- Patients who have not previously received asthma education
- Able to provide signed informed consent
You will not qualify if you...
- Do not have a mobile device with Android or iOS system
- Lack the minimum technological knowledge to use the ESTOI application
- Participated in a clinical trial within the last 6 months
- Diagnosed with respiratory diseases other than obstructive sleep apnea or Asthma-COPD overlap syndrome
- Have palliative or severe chronic illnesses limiting life expectancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bellvitge University Hospital
Barcelona, Barcelona, Spain, 08907
Actively Recruiting
Research Team
H
Héctor Cabrerizo Carreño, M.N
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here